Not sure of the woman's name, but her comments were actually highly in favor of early approval for eteplirsen. That being said, she did not actually "eteplirsen" or if she did, I missed it. Net positive regardless.
Yep, all of the groups that have a financial stake. Groups run by parents with a direct relationship to children with DMD are being ignored by the FDA.
The one thing I notice here is that most of these foundations are foundations created by individual parents. It seems the big bureaucratic groups are nowhere to be seen. Guess money really does talk.
This list comes from Thunderclap. It's a long list, and as expected, certain groups are missing. What the eff is wrong with those other groups?
Action Duchenne, Alex's Wish, Charley's Fund, Coalition Duchenne, Duchenne Foundation, Duchenne Ireland, Duchenne Now, Foundation for a Future, Foundation For Their Sake, Foundation to Eradicate Duchenne, Harrison's Fund, Hope for Gus, Hope for Javier, JB's Keys, Jett Foundation, John Owen's Adventure, Inc (JOA), Joining Jack, Liam's Leep, Little Hercules Foundation, Michael's Cause, Misko Foundation, Muscular Dystrophy Australia, Muscular Dystrophy Foundation India, Nash Avery Foundation, Pietro's Fight, RaceMD, Rally for Ryan, Romito Foundation, Ryan's Quest, Suneels Light, Team Joseph, Team Saij, The Duchenne Children's Trust, The Duchenne Research Fund, Two Smiles One Hope Foundation, Zack Heger Foundation, Zubin's Wish
Honestly, yes. Doubtful it ever gets back to $3.83 anytime soon without some highly manipulative pumping. ICT-107 is dead despite what others are telling you.
Are you kidding? This is a falling knife that shouldn't be touched for days if not weeks. There will be a bounce at some point, but it isn't from here, and when it comes, it won't last long. This company is toast at this point.
You clearly don't understand how early-stage biotechs are traded. They aren't traded on revenue growth. They're traded on potential revenue growth and upcoming catalysts.
The thumbs down votes indicate to me that some people don't understand sarcasm. Will. Respond. Like. Robot. From. Now. On.
Your screen name indicates to me that you have our best interests at heart. Thanks for the heads up. Selling now and won't rebuy until the stock hits $6.04.
I don't normally believe in such conspiracies, but I think you're right on this one. With overwhelming odds of the drug being approved and recent big buys by biotech experts Perceptive, this seems like a shake out for some other big players to jump on board.
The silence doesn't mean anything one way or another. I want to see the company succeed and the boys get this drug ASAP, but this is nothing more than a wilda$$ guess based on what we all want to happen.
Huh? You've been posting all day telling people to sell, so you're basically calling them morons and then telling them to sell for a loss. Good advice. Anybody buying at these levels might not catch the exact low, but they'll be perfectly content within a couple of months. It's what called scaling. Look it up.
Nope. You sell at $10. Between now and $8, you buy.
Only people like me are accumulating when the price is down on low volume and selling when the price is up on high volume. But I'm sure you understand that as I imagine you're doing the exact same thing for yourself. (Or whatever group of dishonest thieves you're working for.)
Shouldn't you have switched when it was over 10 and above 70 on the RSI? That's what the smart shorts did.
Um, if the P3 trial is positive, the stock will EASILY hit $3. The stock will likely hit $3 before results are even released. Have you never played a run-up before?